CYNTHIA WADE: Open Payments
NPI 1205356045 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$446 in 23 payments from 9 companies in 2025. Trend: 2023 $978 · 2024 $1,214 · 2025 $446
Food & beverage: $446
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $158 |
| Aimmune Therapeutics, Inc. | 3 | $104 |
| Phathom Pharmaceuticals, Inc. | 2 | $49 |
| Intercept Pharmaceuticals, Inc. | 2 | $31 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
| Ardelyx, Inc. | 1 | $22 |
| Madrigal Pharmaceuticals | 1 | $21 |
| Janssen Biotech, Inc. | 1 | $21 |
| Olympus America Inc. | 1 | $17 |
Products named: ZENPEP, LINZESS, VOQUEZNA, RINVOQ, SKYRIZI, OCALIVA, XIFAXAN, IBSRELA.
Industry payments across TX — which companies pay providers there.
